Kempner Capital Management Inc. Organon & Co. Transaction History

Kempner Capital Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$13.78 - $18.8 $68 - $94	-5 Reduced 0.01%	68,361 $1.29 Million
Q4 2023 Jan 24, 2024	SELL	$10.95 - $17.32 $369,365 - $584,238	-33,732 Reduced 33.04%	68,366 $985,000
Q4 2022 Jan 13, 2023	SELL	$23.31 - $28.61 $12,867 - $15,792	-552 Reduced 0.54%	102,098 $0
Q3 2022 Oct 11, 2022	BUY	$23.4 - $34.25 $442,821 - $648,147	18,924 Added 22.6%	102,650 $2.4 Million
Q2 2022 Jul 19, 2022	SELL	$31.66 - $38.9 $72,026 - $88,497	-2,275 Reduced 2.65%	83,726 $2.83 Million
Q1 2022 Apr 13, 2022	SELL	$30.45 - $39.36 $2.48 Million - $3.2 Million	-81,381 Reduced 48.62%	86,001 $3 Million
Q4 2021 Jan 18, 2022	SELL	$28.67 - $37.13 $14,076 - $18,230	-491 Reduced 0.29%	167,382 $5.1 Million
Q2 2021 Jul 23, 2021	BUY	$28.45 - $38.0 $4.78 Million - $6.38 Million	167,873 New	167,873 $5.08 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Kempner Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Kempner Capital Management Inc. with notifications on news.